WebMyllia Biotechnology kombiniert CRISPR-Screening mit Einzelzell-RNA-Sequenzierung und nutzt zwei transformative Technologien, um ein genetisches Screening auf komplexe Phänotypen zu ermöglichen. Wir nutzen den CROP-seq-Workflow, um die Auswirkungen von Tausenden von genetischen Störungen auf das globale Transkriptom abzubilden. WebMyllia Biotechnology 2,311 followers 1y Report this post Report Report. Back ...
Homepage Vienna BioCenter Leading life science cluster
WebMyllia Biotechnology (Aelian Biotechnology) Export CELLECTA, INC. n/a Founded 2006 USA Cellecta, Inc. was founded in April 2006 by one of the chief scientists from Clontech … WebMyllia Biotechnology combines CRISPR screening with single-cell RNA sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. We utilize the CRISPR screening workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively ... dhaka to male air ticket price
Thomas Moser - CEO - bit.bio discovery LinkedIn
WebApr 14, 2024 · Abstract. CRISPR screens have become the primary discovery engine in modern biology. However, many screening workflows are still performed in cancer cell lines and coupled to simplistic read-outs such as cellular fitness. At Myllia Biotechnology, we combine CRISPR screening with single-cell RNA sequencing, leveraging two … WebMyllia Biotechnology 2.312 Follower:innen auf LinkedIn. Single-Cell CRISPR Screening - a powerful approach to identify drug targets or elucidate mechanisms of actions of drugs Myllia Biotechnology combines CRISPR screening with single-cell sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. WebMyllia Biotechnology combines CRISPR screening with single-cell RNA sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. cid f82.0